Milnacipran Film-Coated Tablets Film-coated Tablets Suppliers & Bulk Manufacturers

Available Forms: Film-coated Tablets

Available Strengths: Film-coated Tablets

Reference Brands: Savella(US); Ixel®, Toledomin(EU)

Category: Antipsychotropic Drugs

Milnacipran is a serotonin-norepinephrine reuptake inhibitor (SNRI) that increases the availability of these neurotransmitters in the central nervous system. It is primarily used to treat fibromyalgia and major depressive disorder (MDD) in some regions. Its balanced dual action helps reduce pain, fatigue, and mood-related symptoms in affected patients.

Product Description: In the United States, milnacipran film-coated tablets are FDA-approved primarily for the management of fibromyalgia, not for depression, although it's classified as a serotonin-norepinephrine reuptake inhibitor (SNRI). Regulatory requirements include boxed warnings for increased suicidal risk in young adults, GMP compliance, and post-marketing surveillance. Manufacturers must provide evidence of bioavailability, long-term safety, and labeling accuracy. In the European Union, milnacipran is approved under various national procedures for the treatment of major depressive disorder (MDD), with less emphasis on fibromyalgia. EU regulations mandate a Risk Management Plan (RMP), pharmacovigilance systems, and Periodic Safety Update Reports (PSURs). For dossier-ready supply and partnerships, visit Pharmatradz.com.